Novartis flu vaccine ban lifted in under 3 weeks
This article was originally published in Scrip
Executive Summary
The Italian medicines agency AIFA has lifted the precautionary temporary ban on Novartis's flu vaccines after tests showed that there were no quality defects with commercialised lots. AIFA's latest move follows the lifting of bans imposed by regulators in Switzerland and Canada on 31 October and in Singapore on 2 November after they also concluded that there were no quality concerns (scripintelligence.com, 2 November 2012).